MeSH term
Frequency | Condition_Probility | Female | 31 | 0.0 |
Humans | 71 | 0.0 |
Pregnancy | 2 | 0.0 |
Age Factors | 2 | 0.0 |
Animals | 17 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Argininosuccinate Synthase/genetics/metabolism | 2 | 100.0 |
Blotting, Northern | 5 | 0.0 |
Carbamoyl-Phosphate Synthase (Ammonia)/genetics/metabolism | 2 | 100.0 |
Male | 34 | 0.0 |
*Membrane Transport Proteins | 4 | 0.0 |
Mice | 9 | 0.0 |
*Mitochondrial Proteins | 4 | 2.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Base Sequence | 12 | 0.0 |
DNA Primers | 2 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Adult | 21 | 0.0 |
Aged | 8 | 0.0 |
Middle Aged | 15 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Arginine/metabolism | 3 | 5.0 |
Citrulline/metabolism | 3 | 33.0 |
English Abstract | 4 | 0.0 |
Mutation | 3 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Chromosomes, Human, Pair 9 | 4 | 2.0 |
Comparative Study | 6 | 0.0 |
In Situ Hybridization, Fluorescence/*methods | 2 | 2.0 |
Translocation, Genetic | 2 | 0.0 |
Arginine/*metabolism | 2 | 4.0 |
Brain/*metabolism | 2 | 0.0 |
Adolescent | 8 | 0.0 |
Age of Onset | 5 | 0.0 |
Blotting, Western | 2 | 0.0 |
Child | 6 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Liver/enzymology | 5 | 0.0 |
*Mutation | 5 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Genotype | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Alleles | 5 | 0.0 |
Amino Acids/blood | 2 | 4.0 |
Homozygote | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Argininosuccinate Synthase/*deficiency/*genetics | 2 | 100.0 |
Infant | 5 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Argininosuccinate Synthase/deficiency/genetics | 2 | 100.0 |
Cloning, Molecular | 3 | 0.0 |
Argininosuccinate Synthase/*deficiency | 3 | 100.0 |
Citrulline/*blood | 13 | 86.0 |
Liver/enzymology/pathology | 3 | 18.0 |
Amino Acid Metabolism, Inborn Errors/*genetics/metabolism | 2 | 50.0 |
Chromosome Mapping | 9 | 0.0 |
*Chromosomes, Human, Pair 9 | 13 | 5.0 |
Consanguinity | 3 | 0.0 |
Genes, Recessive | 3 | 0.0 |
Genetic Markers | 8 | 0.0 |
Infant, Newborn | 7 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Urea/metabolism | 4 | 8.0 |
Ammonia/blood | 4 | 11.0 |
Argininosuccinate Synthase/*deficiency/metabolism | 3 | 100.0 |
Argininosuccinate Synthase/genetics | 4 | 66.0 |
Child, Preschool | 5 | 0.0 |
DNA/genetics | 3 | 0.0 |
Linkage (Genetics) | 4 | 0.0 |
Lod Score | 5 | 0.0 |
Pedigree | 12 | 0.0 |
Phenotype | 3 | 0.0 |
Dystonia Musculorum Deformans/*genetics | 3 | 15.0 |
Haplotypes | 4 | 0.0 |
Jews/*genetics | 4 | 2.0 |
Polymorphism, Genetic | 2 | 0.0 |
Biopsy | 3 | 0.0 |
Chromosome Disorders | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Genetic Screening | 3 | 0.0 |
Heterozygote | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Urea/*metabolism | 2 | 9.0 |
Amino Acid Metabolism, Inborn Errors/*genetics | 2 | 5.0 |
Argininosuccinate Synthase/*genetics | 8 | 88.0 |
Gene Expression/genetics | 2 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Benzoic Acid | 2 | 22.0 |
Ethnic Groups | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
*Linkage (Genetics) | 5 | 0.0 |
Aspartic Acid/metabolism | 2 | 7.0 |
Cell Division/drug effects | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
Hamsters | 4 | 0.0 |
Hybrid Cells | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Argininosuccinate Synthase/*metabolism | 2 | 66.0 |
Cell Line | 4 | 0.0 |
Ligases/*genetics | 3 | 2.0 |
Liver/*enzymology | 3 | 0.0 |
Argininosuccinate Synthase/*deficiency/genetics | 2 | 66.0 |
Citrulline/*blood/metabolism | 2 | 100.0 |
Ligases/*deficiency | 4 | 40.0 |
